Welcome to Stanford Immunology
The FDA is funding a collaboration between Stanford and UCSF to improve the regulatory infrastructure that helps to shape modern biomedical research. The UCSF-Stanford center launched in 2014 with an initial $3.3 million grant from the FDA to develop projects that can help with regulating health care. For example, one project, headed by Russ Altman, MD, PhD, professor of bioengineering, of genetics of medicine and of biomedical data science at Stanford, uses natural language processing and machine learning to analyze the contents of enormous databases of adverse effects from drugs reported by patients and clinicians.
Seed grants were awarded to seven faculty teams and individuals, as well as to eight young investigators, for the coming year. The Stanford Institute for Immunity, Transplantation and Infection has awarded seed grants to 15 interdisciplinary research projects led by faculty members and young investigators.
Blocking a cell surface protein called CD47 may effectively treat at least one kind of cancer in dogs, according to a study by researchers at the School of Medicine and other institutions. The work expands on research by Irving Weissman, MD, professor of pathology and of developmental biology, and his colleagues, who found that blocking CD47 might be useful in treating nearly every kind of human cancer.
Monitoring cancer DNA in blood can predict recurrence and prognosis and drive treatment decisions. A Stanford study of 92 lymphoma patients suggests similar techniques may work for other tumors. Maximilian Diehn, MD, PhD, and Ash Alizadeh, MD, PhD have found a way to monitor cancer DNA in the blood of patients with lymphoma, which could help identify patients that are likely to be treated successfully. Alizadeh and assistant professor of radiation oncology Maximilian Diehn share senior authorship of the study, which was published Nov. 9 in Science Translational Medicine. Postdoctoral scholars Florian Scherer, MD, and David Kurtz, MD, and instructor Aaron Newman, PhD, are the lead authors.
Stanford faculty members in medicine and in Earth science have been elected fellows of the American Association for the Advancement of Science. Lawrence Steinman, MD, professor of neurology and neurological sciences, was selected for discoveries about the molecular basis for lymphocyte homing to the brain in relapsing multiple sclerosis, which led to an effective approved therapy for multiple sclerosis. Steinman, who holds the George A. Zimmermann Professorship, focuses his research on understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis.
The academy elected Stanford faculty members Laura Carstensen, Christopher Garcia, Mark Krasnow, Mark Musen and Thomas Rando to its membership.
Maria Birukova, 1990-2016
Stanford Immunology is grieving the tragic loss of Maria Birukova, an MD/PhD student who began her Stanford studies in August 2013. Maria died after a climbing accident on Sunday, September 18 in Bishop, CA. A memorial service to honor Maria is being planned for later this fall.
2016 Asilomar Retreat Prize Results!
Michael Bscheider, Roshni Roy Chowdhury, Erika Bongen, and Ian Linde won the best postdoc and graduate student posters at this year's annual Immunology retreat.
Click HERE to visit the Asilomar page.
Photo courtesy of Albert Tsai
Stanford Immunology Students Combat Anti-Vaccine Movement with Video - "I Just Can't Wait for My Vaccine."
Click here to get your copy of the Program Handbook!
From the desk of Dr. Patricia Jones, Director
Stanford Immunology is home to faculty, students, postdocs and staff who work together to produce internationally recognized research in many fields of immunology. The long tradition of collaboration among the immunology laboratories at Stanford fosters highly productive interdisciplinary research, with an emphasis on the application of molecular approaches to problems in cellular and clinical immunology. Faculty research interests include both bench-to-bedside approaches and basic science research. Graduate students and postdoctoral scholars receive outstanding training through their participation in research, teaching, seminars, journal clubs, and the annual Stanford Immunology Scientific Conference. Many members of our community are also affiliated with Stanford Institutes of Medicine. Stanford Immunology joined the Institute of Immunity, Transplantation and Infection in January 2011.